Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S)   FALL 2006 , Volume 24 , Number 82; Page(s) 40 To 43.
 
Paper: 

COMPARISON OF THE THERAPEUTIC EFFICACY OF CONCOMITANT ADMINISTRATION OF LEVAMISOLE AND CLOBETASOL WITH CLOBETASOL IN VITILIGO

 
 
Author(s):  NASERI MAHSA*
 
* SHIRAZ UNIVERSITY
 
Abstract: 

Introduction: Vitiligo is an acquired pigmentary disorder of the skin and has significant harmful effects on the appearance and consequently Social functions of the patients. There is no universally effective treatment for this disease, but topical steroids and levamisole have been used. This study evaluates the effects of levamisole and clobetasol with that of clobetasol in the treatment of vitiligo.

Methods: Through a randomized clinical trial, 73 adult patients with vitiligo were divided into two groups. The first group consisted of 37 patients and received levamisole 150 mg daily for 2 consecutive days per week, and topical clobetasol ointment 0.05% daily. The second group consisted of 36 patients and received topical clobetasol ointment 0.05% daily. Treatment was continued for 4 months and 35 patients in each group completed the study.

Of seventy patients who completed the study, 32 were males, and 3,8 were females aged between 18 and 55 years. In the first, group, 37.1% showed no response, another 37.1% had partial response and 25.8% showed complete response to treatment. In the second, group these 3 types of responses were observed in 25.7%, 54.3% and 20% of subjects, respectively. There was no statistically significant difference between the responses of the two groups.

Conclusions: It seems that addition of levamisole to d6betasol is not helpful in the treatment of vitiligo.
 
Keyword(s): LEVAMISOLE, CLOBETASOL, VITILIGO
 
References: 
  • ندارد
 
  Persian Abstract Yearly Visit 76
 
Latest on Blog
Enter SID Blog